- Home
- KALA
KALA
KALA BIO Inc.
as 05-07-2025 1:38pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as KALA BIO Inc. KALA prepares to release earnings report on 13 May 2025.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | N/A | IPO Year: | 2017 |
| Target Price: | $15.00 | AVG Volume (30 days): | 82.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -10.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.92 - $11.20 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest KALA BIO Inc. News
KALA Breaking Stock News: Dive into KALA Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2 months ago
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
GlobeNewswire
3 months ago
KALA BIO Announces Chief Executive Officer Transition
GlobeNewswire
4 months ago
KALA BIO Announces $10,750,000 Private Placement
GlobeNewswire
5 months ago
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire
6 months ago
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
9 months ago
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire
9 months ago
KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Compare KALA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KALA KALA BIO Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.